Product & FDA Disclaimer
*FDA regulations strictly prohibit the use of therapeutic or medical claims in conjunction with the sale of any product not approved by the FDA. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*The information and products presented on this website are not intended as a substitute for the advice or medical care of a qualified physician. No action should be taken solely on its content. You should not use the information on this web site for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment.
*Dietary supplements supplied by Health & Balance Vitamins Pty Ltd should always be consumed as part of a holistic plan that incorporates nutrition, exercise, stress management and quality sleep. We do not recommend using this product in the absence of the aforementioned lifestyle factors.
*This product is a dietary supplement.
References
Ashkar, F., Rezaei, S., Salahshoornezhad, S., Vahid, F., Gholamalizadeh, M., Dahka, S. M., & Doaei, S. (2020). The Role of medicinal herbs in treatment of insulin resistance in patients with Polycystic Ovary Syndrome: A literature review. Biomolecular concepts, 11(1), 57-75.
Manouchehri, A., Abbaszadeh, S., Ahmadi, M., Nejad, F. K., Bahmani, M., & Dastyar, N. (2023). Polycystic ovaries and herbal remedies: A systematic review. JBRA assisted reproduction, 27(1), 85.
Kamal, D. A. M., Salamt, N., Zaid, S. S. M., & Mokhtar, M. H. (2021). Beneficial effects of green tea catechins on female reproductive disorders: A review. Molecules, 26(9), 2675.
Ionescu, O. M., Frincu, F., Mehedintu, A., Plotogea, M., Cirstoiu, M., Petca, A., ... & Mehedintu, C. (2023). Berberine—A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women. Life, 13(1), 125.
Xia, Q., Wang, W., Liu, Z., Xiao, J., Qiao, C., Zhao, Y., ... & Wang, D. (2022). New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties. European Journal of Pharmacology, 175433.
Mishra, N., Verma, R., & Jadaun, P. (2022). Study on the effect of berberine, myoinositol, and metformin in women with polycystic ovary syndrome: a prospective randomised study. Cureus, 14(1).